⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of F.I.S. - Fabbrica Italiana Sintetici S.p.A. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
F.I.S. - Fabbrica Italiana Sintetici S.p.A.
↗Montecchio Maggiore, Italy
FIS is a leading European Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of small-molecule active pharmaceutical ingredients (APIs) and intermediates. With over 60 years of experience, the company provides comprehensive services ranging from process research and development to large-scale commercial manufacturing.
The company operates state-of-the-art facilities in Italy (Montecchio Maggiore, Termoli, and Lonigo) and maintains a global presence with offices in North America and Japan, as well as operational sites in China and India. FIS is recognized for its innovation, quality management, and sustainability practices, serving as a trusted partner to pharmaceutical companies worldwide.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$800M-$1B
Founded:1957
Ownership:private
Status:operating
FUNDING
Investors:Bain Capital Private Equity
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (CDMO)
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:SQ Innovation (Long-term API supply for Lasix ONYU)
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Daniele Piergentili - CEO and Chairman
LINKS
Website:fisvi.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with F.I.S. - Fabbrica Italiana Sintetici S.p.A.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.